Combination drug therapy for childhood brain tumors shows promise in laboratory models
(Johns Hopkins Medicine) In experiments with human cells and mice, researchers at the Johns Hopkins Kimmel Cancer Center report evidence that combining the experimental cancer medication TAK228 (also called sapanisertib) with an existing anti-cancer drug called trametinib may be more effective than either drug alone in decreasing the growth of pediatric low-grade gliomas. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 17, 2020 Category: International Medicine & Public Health Source Type: news

Glioma Trials Should Track Living Well, Not Just Longer Glioma Trials Should Track Living Well, Not Just Longer
Neuro-oncology working group backs focus on how patients feel, function.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 11, 2020 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Finding a cure for Fido's brain cancer may help us find a cure for ourselves
(Jackson Laboratory) For cancers such as glioma, preclinical research models have failed to provide sufficient insight for medical progress. A team led by Jackson Laboratory's Roel Verhaak thoroughly analyzed sporadic canine gliomas and found that their molecular characteristics, including gene mutations and duplications, resemble those of humans. The results indicate that dogs provide an effective model for human gliomas, and learning how to more effectively treat our pets will likely inform better prognoses for human patients. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 10, 2020 Category: Cancer & Oncology Source Type: news

Poliovirus therapy shows potential as cancer vaccine in lab studies
A modified form of poliovirus, pioneered at Duke Cancer Institute as a therapy for glioblastoma brain tumors, appears in laboratory studies to also have applicability for pediatric brain tumors when used as part of a cancer vaccine. In preclinical studies using mice and human cancer cells, an injection of the modified poliovirus vector instigated an immune response that homed in on mutated cancer cells that predominate in diffuse midline glioma (DMG) tumors. The cancer strikes children and is universally deadly. (Source: World Pharma News)
Source: World Pharma News - January 30, 2020 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Brain tumors remodel neuronal synapses to promote growth
(Baylor College of Medicine) Scientists discovered that glioma, a lethal form of brain cancer, alters the activity of neighboring neurons, accelerating a vicious cycle that drives tumor-associated epilepsy and tumor progression. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 29, 2020 Category: Cancer & Oncology Source Type: news

Study uncovers unexpected connection between gliomas, neurodegenerative diseases
(Michigan Medicine - University of Michigan) New basic science and clinical research identifies TAU, the same protein studied in the development of Alzheimer's, as a biomarker for glioma development. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 22, 2020 Category: Cancer & Oncology Source Type: news

Surgery May Add Years for Patients With Deadly Brain Cancer: Study
WEDNESDAY, Jan. 20, 2020 -- Surgical removal of the entire tumor may extend the lives of patients with a rare and deadly type of brain cancer called brainstem high-grade gliomas, a new study suggests. Researchers analyzed data from 103 patients in... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 15, 2020 Category: General Medicine Source Type: news

Peering into the genome of brain tumor
(Osaka University) Scientists at Osaka University have created a machine learning method for classifying the mutations of glioma brain tumors based on MR images alone. Thus far, classification has only been possible by tissue sampling during surgery. The new method is noninvasive, may remove the need for a tissue sample and help accelerate delivery of treatment for patients. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 9, 2020 Category: Cancer & Oncology Source Type: news

Connecticut boy, seven, with fatal brain tumor spends last Christmas home
Trenton O'Brien, seven, of East Haven, Connecticut, was diagnosed with a brain tumor called Diffuse Intrinsic Pontine Glioma in June 2019. He's been home, in hospice care, since Christmas Eve. (Source: the Mail online | Health)
Source: the Mail online | Health - January 6, 2020 Category: Consumer Health News Source Type: news

New Mom With Brain Tumor Turns To Boston Hospital For Keyhole Brain Surgery
BOSTON (CBS) — Imagine giving birth to a premature baby and then being told you have a brain tumor. That’s what happened to a woman from Holden. But thanks to a new approach at Brigham and Women’s Hospital, this new mom was able to have brain surgery and quickly return to her newborn son. At 27 weeks pregnant, Bethany Shea was diagnosed with preeclampsia and had an emergency C-section. Then she went blind. “It was a pregnancy complication due to my high blood pressure,” Bethany explained. Bethany regained her vision, but worried she had had a stroke, doctors ordered an MRI. But instead of a st...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - December 30, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Healthwatch Seen On WBZ-TV Syndicated CBSN Boston Syndicated Local Brigham and Women's Hospital Dr. Mallika Marshall Source Type: news

Perioperative Study of Vorasidenib Shows Promise for Patients with Low-Grade Glioma
A perioperative study confirmed brain penetrance and robust biomarker suppression in patients with low-grade glioma with an IDH1 mutation. (Source: CancerNetwork)
Source: CancerNetwork - November 27, 2019 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news

NF decline but stable QOL in 1st year after temozolomide-based chemoradiotherapy
(NRG Oncology) A secondary analysis of the NRG Oncology clinical trial NRG-RTOG 0424, which initially reported a 73.1% 3-year overall survival rate, shows a decline in neurocognitive function (NCF) for half of the trial participants with high risk, low-grade gliomas (HR-LGGs) up to a year after receiving concurrent chemoradiotherapy with temozolomide. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 25, 2019 Category: Cancer & Oncology Source Type: news

Scientists drug combo that may give some hope for lethal childhood brain cancer sufferers
After using computer algorithms to sour through 9,000 possible drug combinations, Stanfors scientists found a pair with potential for treating diffuse intrinsic glioma, a rare and lethal childhood cancer. (Source: the Mail online | Health)
Source: the Mail online | Health - November 22, 2019 Category: Consumer Health News Source Type: news

Scientists find promising drug combination against lethal childhood brain cancers
(NIH/National Center for Advancing Translational Sciences (NCATS)) Researchers have devised a new, promising plan of attack against deadly childhood brain cancers called diffuse midline gliomas (DMG). NCATS and Stanford University scientists and their colleagues showed that combining two drugs killed DMG patient cells grown in the laboratory and in animal models. The drugs countered the effects of a genetic mutation that causes the diseases. Their studies also uncovered an unrecognized vulnerability in the cancer cells that scientists may be able to exploit. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 20, 2019 Category: International Medicine & Public Health Source Type: news

How do gliomas evolve?
(Jackson Laboratory) The Glioma Longitudinal Analysis (GLASS) Consortium characterized diffuse glioma cells both before and after therapy to characterize how they change and why this form of malignant brain cancer is so difficult to treat. The findings provide a foundation for further research and the opportunity for the clinical community to predict the effectiveness of newly developed treatments. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - November 20, 2019 Category: Biology Source Type: news

Pioneering blood test which uses AI to quickly scan for brain tumours is up to 90% accurate
The test, developed by University of Edinburgh, was able to identify signs gliomas, the most common form of brain tumour, with a 90 per cent success rate. (Source: the Mail online | Health)
Source: the Mail online | Health - November 7, 2019 Category: Consumer Health News Source Type: news

Science Saturday: Glioma Forecast? Excellent Chance for Better Weather says Researcher
Entering the Mathematical Neuro-Oncology lab on Mayo Clinic's location in Scottsdale, Arizona, is like walking onto the bridge of a ship in some fictional universe. There's a definite "Star Trek" vibe. "Yes, 'Star Trek' is good," laughs Kristin Swanson, Ph.D., a mathematical oncologist at Mayo Clinic, "but I like 'Big Bang Theory.' I kind of joke that that's [...] (Source: Mayo Clinic Research News)
Source: Mayo Clinic Research News - October 26, 2019 Category: Research Source Type: news

Be mindful of respiratory, motion issues with GBCAs
A comparison of two gadolinium-based contrast agents (GBCAs) for hepatobiliary...Read more on AuntMinnie.comRelated Reading: Ga-68 PSMA PET/MRI, mpMRI work for prostate cancer analysis Study shines more light on GBCA-related adverse reactions Gadolinium in gliomas, adjacent tissue raises questions German study may offer new way to detect gadolinium FDA adds 8 gadolinium MRI agents to medication guide (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 22, 2019 Category: Radiology Source Type: news

Six-year-old ’s death leads to hope of new drug for childhood cancer
Parents of Abbie Mifsud created the charity that has funded vital research on brain stem tumoursResearchers say they are close to testing a drug that could tackle a previously untreatable childhood brain cancer. The condition is known as DIPG – diffuse intrinsic pontine glioma – and every year it affects between 30 to 40 boys and girls, aged between five and 10. All develop tumours caused by the condition and die, often within months of their diagnoses.But now scientists believe they may soon be able to tackle the condition – and one of the key organisations involved is a remarkable charity set up by Aman...
Source: Guardian Unlimited Science - October 20, 2019 Category: Science Authors: Robin McKie, Observer Science Editor Tags: Drugs Health Science Society UK news Source Type: news

RT improves elderly brain cancer patient survival
A radiation therapy (RT) treatment that combines radiation with chemotherapy...Read more on AuntMinnie.comRelated Reading: Intelerad to launch enterprise software at RANZCR 2019 RANZCR issues final version of ethical AI guidelines RANZCR praises government pledge to support MRI access RANZCR proposes ethical guidelines for AI Virtual reality may help plan, guide glioma resection (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 18, 2019 Category: Radiology Source Type: news

RT boosts elderly brain cancer patient survival
A radiation therapy (RT) treatment that combines radiation with chemotherapy...Read more on AuntMinnie.comRelated Reading: Intelerad to launch enterprise software at RANZCR 2019 RANZCR issues final version of ethical AI guidelines RANZCR praises government pledge to support MRI access RANZCR proposes ethical guidelines for AI Virtual reality may help plan, guide glioma resection (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 18, 2019 Category: Radiology Source Type: news

3D VR models improve kidney-sparing surgery outcomes
Examining 3D virtual reality (VR) models during presurgical planning for robotic-assisted...Read more on AuntMinnie.comRelated Reading: AR offers 3D image guidance for interventional procedures 4 practical applications of VR, AR in radiology VR, AR elevate radiologists' value in future of medicine Virtual reality may help plan, guide glioma resection Virtual reality, 3D printing resolve obscure lung cancer (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 18, 2019 Category: Radiology Source Type: news

FET-PET can be useful for glioma evaluations
When glioma results are inconclusive on MRI, clinicians should consider fluoroethyl-tyrosine...Read more on AuntMinnie.comRelated Reading: How cost-effective is intraoperative MRI for gliomas? FET-PET adds 'relevant' info to pediatric cancer cases FLT-PET points toward survival for glioblastoma patients SNMMI: FET-PET could have answers for brainstem glioma SNMMI: FET-PET aids pediatric brain cancer patients (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 18, 2019 Category: Radiology Source Type: news

Tocagen Reports Results of Toca 5 Phase 3 Trial in Recurrent Brain Cancer
Management to host conference call today at 8:30 a.m. Eastern SAN DIEGO, Sept. 12, 2019 -- (Healthcare Sales & Marketing Network) -- Tocagen Inc. (Nasdaq: TOCA), a clinical-stage, cancer-selective gene therapy company, today announced that the Toca 5 P... Biopharmaceuticals, Oncology Tocagen, glioma, brain cancer, gene therapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 12, 2019 Category: Pharmaceuticals Source Type: news

Blue Earth touts talks at ASTRO 2019
Bracco molecular imaging subsidiary Blue Earth Diagnostics is directing attention...Read more on AuntMinnie.comRelated Reading: Bracco to acquire Blue Earth Diagnostics Blue Earth highlights SNMMI 2019 presentations Blue Earth touts presentations at AUA 2019 Blue Earth study reports Axumin can aid glioma diagnosis Blue Earth promotes results for PET/CT agent (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 11, 2019 Category: Radiology Source Type: news

MS patients show signs of gadolinium retention on MRI
Seeing is believing for Italian researchers who used MRI to visually confirm...Read more on AuntMinnie.comRelated Reading: Gadolinium MRI scans most common early in pregnancy GBCA-enhanced MRI does not influence MS progression Contrast not needed for follow-up MRI on MS patients Gadolinium in gliomas, adjacent tissue raises questions German study may offer new way to detect gadolinium (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 10, 2019 Category: Radiology Source Type: news

Virtual reality relieves kids' anxiety over chest x-ray
Educating pediatric patients about their upcoming chest x-ray exam with virtual...Read more on AuntMinnie.comRelated Reading: Pediatric patients go to the dogs for MRI anxiety relief Virtual reality engages patients more than CT, booklets 4 practical applications of VR, AR in radiology VR, AR elevate radiologists' value in future of medicine Virtual reality may help plan, guide glioma resection (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 9, 2019 Category: Radiology Source Type: news

Structured reporting enhances brain tumor MRI
Radiologists who used structured reporting to interpret MRI scans of glioma...Read more on AuntMinnie.comRelated Reading: AI tops recent imaging informatics highlights 3 ways to reduce unnecessary MRI knee scans Structured reporting improves quality of MRI reports Structured radiology reports reduce error rate Consensus is key when developing structured report templates (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 29, 2019 Category: Radiology Source Type: news

Boy, 11, diagnosed with rare inoperable brain tumor - and doctors say he has no chance of survival 
DaJuan Brown Jr, 11, of Buffalo, New York, was diagnosed in May with Diffuse Intrinsic Pontine Glioma, an inoperable brain tumor with a two-year survival rate of just 10%. (Source: the Mail online | Health)
Source: the Mail online | Health - July 9, 2019 Category: Consumer Health News Source Type: news

Bracco to acquire Blue Earth Diagnostics
Contrast developer Bracco Imaging has signed a definitive agreement to acquire...Read more on AuntMinnie.comRelated Reading: Blue Earth highlights SNMMI 2019 presentations Blue Earth touts presentations at AUA 2019 Blue Earth study reports Axumin can aid glioma diagnosis Bracco grants kids' hospital $300K for contrast ultrasound Bracco signs CT research deal with Duke Bracco's SonoVue ultrasound contrast cleared in China (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 27, 2019 Category: Radiology Source Type: news

Outcomes Poor Years After Radiation for Pediatric Glioma Survivors
Survivors treated with radiotherapy and at younger ages had poorer neuropsychological, SES outcomes (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - June 25, 2019 Category: Psychiatry Tags: Neurology, Pediatrics, Psychiatry, Journal, Source Type: news

Outcomes Poor Years After Radiation for Pediatric Glioma Survivors
TUESDAY, June 25, 2019 -- Survivors of childhood low-grade gliomas treated with radiotherapy have poorer neuropsychological and socioeconomic-status (SES) outcomes, according to a study published online June 24 in Cancer. M. Douglas Ris, Ph.D., from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 25, 2019 Category: Pharmaceuticals Source Type: news

Computer - Assisted Diagnosis Aids Detection of Glioma Growth
Physicians using CAD can detect growth of low - grade gliomas at significantly smaller volumes (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - June 20, 2019 Category: Cancer & Oncology Tags: Neurology, Oncology, Radiology, Journal, Source Type: news

Computer-Assisted Diagnosis Aids Detection of Glioma Growth
THURSDAY, June 20, 2019 -- Computer-assisted diagnosis (CAD) can help physicians detect growth of low-grade gliomas, according to a study published online May 28 in PLOS Medicine. Hassan M. Fathallah-Shaykh, M.D., from the University of Alabama at... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 20, 2019 Category: Pharmaceuticals Source Type: news

Blue Earth highlights SNMMI 2019 presentations
Molecular imaging firm Blue Earth Diagnostics is touting 16 presentations involving...Read more on AuntMinnie.comRelated Reading: Blue Earth touts presentations at AUA 2019 Blue Earth study reports Axumin can aid glioma diagnosis Blue Earth promotes results for PET/CT agent Blue Earth expands PSMA-PET/CT imaging portfolio Blue Earth touts addition of Axumin to NCCN guidelines (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 14, 2019 Category: Radiology Source Type: news

Surgical Smoke Helps ID Brain Tumors
A team at Tampere University, Finland has developed a technique using surgical smoke that allows neurosurgeons to ID cancerous tissue during surgery. A new method developed by researchers at Tampere University in Finland helps analyze surgical smoke to distinguish between malignant tissue and health tissue. The researcher’s work was recently published in the Journal of Neurosurgery. The technology is based on differential mobility spectrometry, wherein flue gas ions are fed into an electric field. The distribution of ions in the electric field is tissue-specific, and the tissue can be identified on the ba...
Source: MDDI - June 14, 2019 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news

03.06.19: Not intended for U.S. and UK Media - Annual Meeting of the American Society of Clinical Oncology (ASCO) 2019:
New data on larotrectinib efficacy in patients with TRK fusion cancer and primary CNS tumors or brain metastases presented at ASCO 2019In five TRK fusion cancer patients with brain metastases across different tumor histologies, the overall response rate was 60%, with disease control achieved in all patients / In 14 adult and pediatric patients with TRK fusion cancer with primary central nervous system (CNS) tumors (including high grade gliomas), the overall response rate was 36% including two complete responses / 71% of evaluable patients with primary CNS tumors experienced disease control for 24 weeks or more / First pros...
Source: Bayer IR Newsfeed: Events - June 4, 2019 Category: Pharmaceuticals Source Type: news

New data on larotrectinib efficacy in patients with TRK fusion cancer and primary CNS tumors or brain metastases presented at ASCO 2019 (for specialized target groups only)
In five TRK fusion cancer patients with brain metastases across different tumor histologies, the overall response rate was 60%, with disease control achieved in all patients / In 14 adult and pediatric patients with TRK fusion cancer with primary central nervous system (CNS) tumors (including high grade gliomas), the overall response rate was 36% including two complete responses / 71% of evaluable patients with primary CNS tumors experienced disease control for 24 weeks or more / First prospective analysis of the activity of larotrectinib in patients with TRK fusion cancer and intracranial disease, including first data eve...
Source: Bayer Company News - June 3, 2019 Category: Pharmaceuticals Source Type: news

Blue Earth touts presentations at AUA 2019
Molecular imaging firm Blue Earth Diagnostics is highlighting several presentations...Read more on AuntMinnie.comRelated Reading: Blue Earth study reports Axumin can aid glioma diagnosis Blue Earth promotes results for PET/CT agent Blue Earth expands PSMA-PET/CT imaging portfolio Blue Earth touts addition of Axumin to NCCN guidelines Blue Earth highlights Axumin clinical results at ASTRO (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 6, 2019 Category: Radiology Source Type: news

Mother, 19, who was diagnosed with untreatable brain cancer months before giving birth dies
Dana Scatton, of Pennsylvania, was seven months pregnant in December 2017 when a brain scan revealed she had diffuse intrinsic pontine glioma (DIPG). (Source: the Mail online | Health)
Source: the Mail online | Health - April 25, 2019 Category: Consumer Health News Source Type: news

Virtual reality engages patients more than CT, booklets
Patients with an abdominal aortic aneurysm were more engaged and had a better...Read more on AuntMinnie.comRelated Reading: 4 practical applications of VR, AR in radiology SIR: Virtual reality beats fluoroscopy for catheter placement VR, AR elevate radiologists' value in future of medicine Virtual reality may help plan, guide glioma resection VR software may increase MRI segmentation efficiency (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 25, 2019 Category: Radiology Source Type: news

How Common Are Brain Tumors Seen in Spasmus Nutans?
Discussion Nystagmus is periodic eye movement that is involuntary where there is a slow drift of fixation. The slow drift can be followed by a fast saccade back to fixation. The pathological movement is the slow phase, but nystagmus is described by the fast phase (i.e. horizontal nystagmus, vertical nystagmus). Spasmus nutans (SN) is a movement disorder that is rare. The classic triad includes nystagmus, head bobbing or titubation, and torticollis, with these problems being in the absence of any ophthalmological or neurological condition. Onset is in the first year of life but ranges from 6-36 months. Time to resolution ...
Source: PediatricEducation.org - April 15, 2019 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

How Commonly Are Brain Tumors Seen in Spasmus Nutans?
Discussion Nystagmus is periodic eye movement that is involuntary where there is a slow drift of fixation. The slow drift can be followed by a fast saccade back to fixation. The pathological movement is the slow phase, but nystagmus is described by the fast phase (i.e. horizontal nystagmus, vertical nystagmus). Spasmus nutans (SN) is a movement disorder that is rare. The classic triad includes nystagmus, head bobbing or titubation, and torticollis, with these problems being in the absence of any ophthalmological or neurological condition. Onset is in the first year of life but ranges from 6-36 months. Time to resolution ...
Source: PediatricEducation.org - April 15, 2019 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

How cost-effective is intraoperative MRI for gliomas?
Using a simulated clinical decision analysis model, researchers from the University...Read more on AuntMinnie.comRelated Reading: Workflow optimization cuts MRI turnaround time Imaging analytics platform optimizes MRI operations MRA is cost-effective for kidney disease-related aneurysms Study reveals steep cost of delaying stroke treatment MRI for knee pain adds cost with negligible benefit (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 2, 2019 Category: Radiology Source Type: news

Clinical trial finds therapy to be well-tolerated in patients with aggressive brain tumour
A phase I clinical trial that set out to assess the safety of a new combination therapy for a type of aggressive brain tumour has found the treatment to be well tolerated in patients. The trial used a treatment combination of ADI-PEG20, pemetrexed and cisplatin, which showed encouraging efficacy in patients with recurrent high-grade gliomas (HGGs), a disease for which little progress has been made over the last few decades. (Source: World Pharma News)
Source: World Pharma News - March 29, 2019 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

SIR: Virtual reality beats fluoroscopy for catheter placement
Virtual reality may be a safer, more time-efficient alternative to conventional...Read more on AuntMinnie.comRelated Reading: VR, AR elevate radiologists' value in future of medicine Virtual reality may help plan, guide glioma resection 3D printing gives pediatric heart surgery a boost Virtual reality, 3D printing resolve obscure lung cancer Virtual reality adds depth to brain aneurysm diagnosis (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 26, 2019 Category: Radiology Source Type: news

New drug combination shows promise for common pediatric brain tumor
(Johns Hopkins Medicine) A new combination treatment aimed at resistant and recurrent low-grade gliomas slowed tumor growth and killed tumor cells in laboratory and mouse models. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 21, 2019 Category: International Medicine & Public Health Source Type: news

Augmented reality cultivates early radiology education
An interactive educational course that uses augmented reality technology to...Read more on AuntMinnie.comRelated Reading: VR, AR elevate radiologists' value in future of medicine AR aids image-guided spinal procedures on live patients AR improves operative view for robotic thyroid surgery AR, 3D printing make headway in patient education Virtual reality may help plan, guide glioma resection (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 11, 2019 Category: Radiology Source Type: news

VR, AR elevate radiologists' value in future of medicine
How can virtual reality (VR) and augmented reality (AR) help radiologists advance...Read more on AuntMinnie.comRelated Reading: AR aids image-guided spinal procedures on live patients AR improves operative view for robotic thyroid surgery Virtual reality may help plan, guide glioma resection VR, AR may revamp cardiovascular imaging Virtual reality adds depth to brain aneurysm diagnosis (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 4, 2019 Category: Radiology Source Type: news

Gadolinium breast MRI screening OK for healthy women
VIENNA - Healthy women at high risk for developing breast cancer should have...Read more on AuntMinnie.comRelated Reading: Video from ECR 2019: Alexander Radbruch on gadolinium debate Gadolinium in gliomas, adjacent tissue raises questions German study may offer new way to detect gadolinium Patients report long-term gadolinium presence in urine Gadolinium accumulation might be more widespread than thought (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 4, 2019 Category: Radiology Source Type: news